4-(Oxetan-3-yl)pyridin-2-amine
95%
- Product Code: 46529
CAS:
1427501-89-0
Molecular Weight: | 150.1778 g./mol | Molecular Formula: | C₈H₁₀N₂O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of small molecule drugs targeting various diseases. Its oxetane and pyridine moieties make it valuable for enhancing drug-like properties such as solubility and metabolic stability. It is also explored in the design of kinase inhibitors and other therapeutic agents due to its ability to interact with specific protein targets. Additionally, it finds application in medicinal chemistry for the optimization of lead compounds to improve efficacy and reduce off-target effects.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.050 | 10-20 days | $314.89 |
+
-
|
4-(Oxetan-3-yl)pyridin-2-amine
Used in pharmaceutical research as a key intermediate in the synthesis of biologically active compounds, particularly in the development of small molecule drugs targeting various diseases. Its oxetane and pyridine moieties make it valuable for enhancing drug-like properties such as solubility and metabolic stability. It is also explored in the design of kinase inhibitors and other therapeutic agents due to its ability to interact with specific protein targets. Additionally, it finds application in medicinal chemistry for the optimization of lead compounds to improve efficacy and reduce off-target effects.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :